Clinical Trial Update: Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ferric citrate for treating hyperphosphatemia in patients with chronic kidney disease on hemodialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease
• Hyperphosphatemia

Drugs mentioned

• Ferric citrate (ferric citrate)

Snippet

Sponsor: Sinomune Pharmaceutical Co., Ltd | Conditions: Hyperphosphatemia, End Stage Renal Disease | Phase 3 | Status: COMPLETED